The Gout Market forecast projects a healthy growth trajectory, fueled primarily by the anticipated launch and uptake of novel therapeutic agents over the next decade, which will diversify treatment options beyond the established generic ULTs. The expected market expansion will be driven not just by increasing patient volumes but also by a premiumization of the therapeutic landscape as...